NewAmsterdam Pharma Company N.V. Share Price Today, Forecast Target, Chat & Where To Buy [NAMS]

  • Today's NewAmsterdam Pharma Company N.V. share price is 32.79 (as of 10:06 04-Jun-2026) which is a change of 0.81 or 2.58% from the last closing price of 32.79.
  • With 26,771 shares traded this gives NewAmsterdam Pharma Company N.V. a market capitalisation of 3,851,983,594.
  • NewAmsterdam Pharma Company N.V.'s most recent daily high has been 33.14 and daily low 32.12. The NewAmsterdam Pharma Company N.V. share price 52 week high has been 42.21 and the 52 week low 17.63.
  • Based on the most recent NewAmsterdam Pharma Company N.V. share price opening of 32.79, the current NewAmsterdam Pharma Company N.V. EPS (earnings per share) are -1.77 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying NewAmsterdam Pharma Company N.V. Shares

It currently costs 32.79 to buy one share in NewAmsterdam Pharma Company N.V. (as of 10:06 04-Jun-2026) which is a change of 0.81 or 2.58% from the last closing price of 32.11. To buy shares in NewAmsterdam Pharma Company N.V. you will need a stock trading platform like City Index.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is NewAmsterdam Pharma Company N.V. A Good Investment?

The below NewAmsterdam Pharma Company N.V. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.

Tell us what you think:

Scroll to Top